Sangamo Therapeutics is facing significant challenges, including a bankruptcy filing. The company's situation involves dwindling choices and substantial financial losses, with millions of dollars at stake. Further details about the bankruptcy and its implications are available from The Business Journals.

The situation has also led to more layoffs, affecting the company's workforce. For more information on the developments surrounding Sangamo Therapeutics, readers can refer to the original report.